All Stories

  1. Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)

    Article • British Journal of Clinical Pharmacology, September 2017, Wiley

    Dr Bruce E Miller

  2. Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium

    Article • American Review of Respiratory Disease, March 2016, American Thoracic Society

    Dr Bruce E Miller